Navigation Links
Cancer Cure Coalition Proposes Major Changes at the FDA
Date:2/21/2008

fety, regulators keep raising the bar for approval, especially for innovative, high-tech products."

We at the Cancer Cure Coalition agree with Dr. Miller that "What the FDA needs is competent management, discipline in the ranks, more effective risk- benefit balancing, a commitment to permitting patients to assume more responsibility for the risk of medicines, and the banishment of politics from regulatory decisions and policy."

We think that reform is needed as soon as possible, and we propose the following steps be taken:

1. Substantial additional funding should be given to the FDA to help it fulfill the increase in duties placed upon it by the Congress.

2. The "Food" division should be separated from the "Drug" division. Insuring the safety of food for the United States is an enormous responsibility and would be best performed by an agency dedicated to that purpose.

3. A special study should be made by an independent organization to make sure that the FDA has competent management. Those managers who are incompetent should be replaced. In the "Drug" division, management is needed that will recognize the needs of the patients and that will apply effective risk-benefit balancing.

4. Consideration should be given to using certified non-governmental agencies to perform the oversight of drug testing and the review of new drug applications. This would reduce cost while improving the quality of the review process.

Unless we move for reform now, the FDA will continue to harm the interests of patients, our health industry and the economy of the United States.

Contact:

Charles A. Reinwald, Chairman

Charles Reinwald, Jr., President

Cancer Cure Coalition

561-747-2174

E-mail: cancercurecoal@aol.com

http://www.cancercurecoalition.org

This release was issued through eRele
'/>"/>

SOURCE Cancer Cure Coalition
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Phase I and Phase I/II DCVax(R)-Brain Data Continues to Show Significantly Improved Survival Rates for Brain Cancer Patients
3. Diagnostic Center for Disease: Prostate Biopsy Spreads Prostate Cancer Cells
4. Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
5. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
6. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
7. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
8. Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint
9. Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
10. Cancer Pioneer Reaches Key Agreement on Colon Cancer Drug OncoVAX(R)
11. deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... JERUSALEM , Feb. 27, 2015  Chiasma, Inc., ... lead product for the orphan condition acromegaly, today announced ... round. Participants in the financing included new investors Rock ... chip public investment fund, as well as existing investors ... and ARCH Venture Partners. Chiasma intends ...
(Date:2/26/2015)... , Feb. 26, 2015  Tandem Diabetes Care®, ... company and manufacturer of the t:slim® and t:flex™ Insulin ... offering of 5,250,000 shares of its common stock at ... The net proceeds to Tandem from this offering are ... and commissions and other estimated offering expenses payable by ...
(Date:2/26/2015)... BEND, Ind. , Feb. 26, 2015  Mobility ... announce an agreement with Bank of America (NYSE: ... consumers nationwide to receive financing of the revolutionary MV-1 ... vehicle, designed from the ground up to provide safe ... Approved applicants can use their loan to purchase a ...
Breaking Medicine Technology:Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3
... MONMOUTH JUNCTION, N.J., Sept. 11 Signum Biosciences, Inc has ... Phase II grant by the National Institute of Allergy and ... STM (Signal Transduction Modulator) anti-inflammatory technology for the treatment of ... 2008, NIH/NIAID awarded Signum a SBIR Phase I grant to ...
... , , ROCHESTER, Minn., Sept. 11 ... mice were associated with good central nervous system repair in multiple ... effective therapies for patients with MS and for predicting MS patients, ... European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, ...
Cached Medicine Technology:Signum Biosciences Awarded Phase II SBIR Grant by the NIH for the Treatment of Rosacea 2Researchers Identify Two Genes as Potential Therapeutic Targets for Multiple Sclerosis 2Researchers Identify Two Genes as Potential Therapeutic Targets for Multiple Sclerosis 3
(Date:2/28/2015)... March—also known as National Brain Injury ... and others that suspected head injuries, especially concussions, ... , Concussions are a form of traumatic brain ... There are 1.6-3.8 million sports-related concussions per year. ... is a brain injury. Many athletes suffer knee ...
(Date:2/28/2015)... February 28, 2015 For those people ... person, the Mesothelioma Applied Research Foundation (Meso ... Tuesday, March 3, starting at 9:30 AM. , The ... registration. The broadcast can be accessed through any browser ... . , The Symposium is a unique event that ...
(Date:2/28/2015)... February 28, 2015 India Network ... sponsored visitor health insurance programs for visitors coming to ... Indian elderly parents traveling to the United States are ... diabetes and blood pressure. These diseases are so common ... list them as medical conditions. There were 66.8 million ...
(Date:2/28/2015)... February 28, 2015 The noted Friedman ... that they have officially relaunched their website. The new ... but it contains a new section about their team ... read the full biographies of each Friedman Dental Group ... the website was designed to provide our patients with ...
(Date:2/28/2015)... 2015 Plugin creators from Pixel Film ... A fully customizable transition pack made specifically ... gives users total control over 30 transition presets built ... Pixel Film Studios. “TransFold Volume 2 gives endless possibilities ... Volume 2 from Pixel Film Studios brings back folding ...
Breaking Medicine News(10 mins):Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2
... SANTA MONICA, Calif., July 17 Cord Blood,America, ... today,announced a business update to the marketplace as ... America, an umbilical cord,blood stem cell preservation company ... potential of stem cells to families,nationwide and internationally, ...
... about how they make decisions when feeling stressed, a Queensland ... Dulleck, from the QUT Business Faculty, said stress in the ... fact, a natural reaction that had been given a negative ... of a study that was awarded an Australian Research Council ...
... of meat because of the taste. But according to groundbreaking ... the reason that a beef burger tastes better than a ... values than actual taste. , Authors Michael W. Allen (University ... (National Engineer School for Food Industries and Management, France) conducted ...
... Lack of access to insurance called a primary stumbling block ... care in the United States continues to elude more and ... the first "scorecard" was done in 2006, the nation,s health-care ... more on medical care than any other industrialized nation. , ...
... Fresh Harvest Products,Inc. (OTC Bulletin Board: FRHV.OB) ... long standing commitment to providing consumers with the,best, ... initiative to,build natural and organic brands and products, ... brands,through our network., "We believe that this ...
... 17 Digital Documents, a,provider of turnkey, ... announced today the integration of its Survey,Management ... Protestant healthcare organization in the United States ... annually., "HCAHPS compliance doesn,t have to ...
Cached Medicine News:Health News:Cord Blood America CEO Announces Statement Regarding Expansion and Company Valuation 2Health News:Cord Blood America CEO Announces Statement Regarding Expansion and Company Valuation 3Health News:Cord Blood America CEO Announces Statement Regarding Expansion and Company Valuation 4Health News:Decisions under pressure: it's all in the heartbeat 2Health News:Good news for veggies 2Health News:U.S. Health Care Still Ill, Survey Finds 2Health News:U.S. Health Care Still Ill, Survey Finds 3Health News:Fresh Harvest Products, Inc. Announces New Brand Initiative 2Health News:Innovative HCAHPS Patient Satisfaction Survey Solution Generates Huge Cost-Savings Opportunity for Adventist Health Systems 2
... and chromatic correction for the focal plane, ... flat images for observation and photomicrography by ... wavelengths up to the near UV range ... types of low autofluorescence makes these objectives ...
... C-Apochromat 40x/1.2W Corr was designed to have ... for aqueous specimens (vital sections, cell cultures, ... for compensating differences in cover glass thickness ... and 37C). The correction collar can ...
... The Plan-Neofluar 63x/1.25 Oil Ph3 ... reflected-light reflection contrast. This method ... brightfield microscopy, such as cells ... a Petri dish. Moreover, this ...
... high-power, apochromatically corrected objectives ... the most exacting demands ... are suitable for visual ... 25 mm and feature ...
Medicine Products: